FindTrial
Sign In

A national multicentre prospective cohort study of breast cancer patients undergoing endoscopic retrograde subcutaneous mastectomy combined with pre-pectoral prosthesis+ patch reconstruction and combined with pro-pectoral prosthesis+ patch reconstruction

A national multicentre prospective cohort study of breast cancer patients undergoing endoscopic retrograde subcutaneous mastectomy combined with pre-pectoral prosthesis+ patch reconstruction and combined with pro-pectoral prosthesis+ patch reconstruction

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045932
Enrollment
Unknown
Registered
2021-04-29
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Group A:Retrograde endoscopic subcutaneous gland excision combined with reconstruction of anterior thoracic muscle prosthesis
Group B:Retrograde endoscopic subcutaneous gland excision combined with reconstruction of posterior thoracic muscle prosthesis

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The age of 18 ~ 70 years; 2. BMI >= 18; 3. The distance between the tumor and the nipple is >=2cm; 4. T1-2N0-1M0 or T1-2N0-1M0 or T1-2N0-1M0 or T1-2N0-1M0 or T1-2N0-1M0 after neoadjuvant chemotherapy

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Long-term cosmetic effects;Recent cosmetic effects;—

Countries

China

Contacts

Public ContactDu Zhenggui

West China Hospital of Sichuan University

386844794@qq.com+86 18980605774

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026